These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 33999049)

  • 1. An antibody-based amperometric biosensor for 20S proteasome activity and inhibitor screening.
    Barsan MM; Diculescu VC
    Analyst; 2021 May; 146(10):3216-3224. PubMed ID: 33999049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrochemical assay for 20S proteasome activity and inhibition with anti-cancer drugs.
    Henriques de Jesus CS; Chiorcea-Paquim AM; Barsan MM; Diculescu VC
    Talanta; 2019 Jul; 199():32-39. PubMed ID: 30952265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immobilized Antibodies on Mercaptophenylboronic Acid Monolayers for Dual-Strategy Detection of 20S Proteasome.
    Barsan MM; Sanz CG; Onea M; Diculescu VC
    Sensors (Basel); 2021 Apr; 21(8):. PubMed ID: 33921330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in the expression and the enzymic properties of the 20S proteasome in sugar-starved maize roots. evidence for an in vivo oxidation of the proteasome.
    Basset G; Raymond P; Malek L; Brouquisse R
    Plant Physiol; 2002 Mar; 128(3):1149-62. PubMed ID: 11891269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SPR imaging biosensor for the 20S proteasome: sensor development and application to measurement of proteasomes in human blood plasma.
    Gorodkiewicz E; Ostrowska H; Sankiewicz A
    Mikrochim Acta; 2011 Oct; 175(1-2):177-184. PubMed ID: 21966027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Degradation of oxidized proteins by the 20S proteasome.
    Davies KJ
    Biochimie; 2001; 83(3-4):301-10. PubMed ID: 11295490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptidomimetics Based on
    Cekała K; Trepczyk K; Sowik D; Karpowicz P; Giełdoń A; Witkowska J; Giżyńska M; Jankowska E; Wieczerzak E
    Biomolecules; 2022 Jun; 12(6):. PubMed ID: 35740902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A biosensor study of protein interaction with the 20S proteasome core particle].
    Buneeva OA; Gnedenko OV; Medvedeva MV; Zgoda VG; Ivanov AS; Medvedev AE
    Biomed Khim; 2019 Jun; 65(4):306-310. PubMed ID: 31436171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined treatment of human multiple myeloma cells with bortezomib and doxorubicin alters the interactome of 20S proteasomes.
    Mittenberg AG; Kuzyk VO; Shabelnikov SV; Gorbach DP; Shatrova AN; Fedorova OA; Barlev NA
    Cell Cycle; 2018; 17(14):1745-1756. PubMed ID: 30009671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated plasma 20S proteasome chymotrypsin-like activity is correlated with IL-8 levels and associated with an increased risk of death in glial brain tumor patients.
    Koper-Lenkiewicz OM; Kamińska J; Reszeć J; Dymicka-Piekarska V; Ostrowska H; Karpińska M; Matowicka-Karna J; Tylicka M
    PLoS One; 2020; 15(9):e0238406. PubMed ID: 32886667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of an anticarcinogenic Bowman-Birk protease inhibitor on purified 20S proteasome and MCF-7 breast cancer cells.
    Souza Lda C; Camargo R; Demasi M; Santana JM; de Sá CM; de Freitas SM
    PLoS One; 2014; 9(1):e86600. PubMed ID: 24475156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NRF3-POMP-20S Proteasome Assembly Axis Promotes Cancer Development via Ubiquitin-Independent Proteolysis of p53 and Retinoblastoma Protein.
    Waku T; Nakamura N; Koji M; Watanabe H; Katoh H; Tatsumi C; Tamura N; Hatanaka A; Hirose S; Katayama H; Tani M; Kubo Y; Hamazaki J; Hamakubo T; Watanabe A; Murata S; Kobayashi A
    Mol Cell Biol; 2020 Apr; 40(10):. PubMed ID: 32123008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human 20S proteasome activity towards fluorogenic peptides of various chain lengths.
    Rut W; Drag M
    Biol Chem; 2016 Sep; 397(9):921-6. PubMed ID: 27176742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of the 20S Proteasome by a Novel Family of Inhibitory Proteins.
    Olshina MA; Arkind G; Kumar Deshmukh F; Fainer I; Taranavsky M; Hayat D; Ben-Dor S; Ben-Nissan G; Sharon M
    Antioxid Redox Signal; 2020 Mar; 32(9):636-655. PubMed ID: 31903784
    [No Abstract]   [Full Text] [Related]  

  • 15. Measuring redox effects on the activities of intracellular proteases such as the 20S Proteasome and the Immuno-Proteasome with fluorogenic peptides.
    Bonet-Costa V; Sun PY; Davies KJA
    Free Radic Biol Med; 2019 Nov; 143():16-24. PubMed ID: 31351175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Degradation of damaged proteins: the main function of the 20S proteasome.
    Pickering AM; Davies KJ
    Prog Mol Biol Transl Sci; 2012; 109():227-48. PubMed ID: 22727423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of the P1' and P2' sites of IQF substrates and their selectivity toward 20S proteasome subunits.
    Gladysz R; Malek N; Rut W; Drag M
    Biol Chem; 2023 Feb; 404(2-3):221-227. PubMed ID: 36376064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of DNA binding on the degradation of oxidized histones by the 20S proteasome.
    Ullrich O; Sitte N; Sommerburg O; Sandig V; Davies KJ; Grune T
    Arch Biochem Biophys; 1999 Feb; 362(2):211-6. PubMed ID: 9989929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic characterization of the chymotryptic activity of the 20S proteasome.
    Stein RL; Melandri F; Dick L
    Biochemistry; 1996 Apr; 35(13):3899-908. PubMed ID: 8672420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Degradation of oxidized proteins by the proteasome: Distinguishing between the 20S, 26S, and immunoproteasome proteolytic pathways.
    Raynes R; Pomatto LC; Davies KJ
    Mol Aspects Med; 2016 Aug; 50():41-55. PubMed ID: 27155164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.